Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan
· Delayed Price · Currency is TWD 14.00
+0.05 (0.36%)
Apr 29, 2026, 1:43 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.34 billion as of April 29, 2026. Its market cap has decreased by -22.94% in one year.
Market Cap
1.34B
Enterprise Value
2.25B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.00
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.34B, a decrease of -31.20%. That is a compound annual growth rate of -12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.34B | -6.92% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.36B |
| Abnova (Taiwan) | 1.31B |
| NeoCore Technology | 1.42B |
| BiOptic | 1.21B |
| GenMont Biotech Incorporation | 1.54B |
| LabTurbo Biotech | 1.15B |
| Advagene Biopharma | 1.57B |
| GeneReach Biotechnology | 1.13B |